YouTube Facebook LinkedIn Google+ Twitter Xinginstagram rss  

Foundation Medicine's IPO Prospects

August 1, 2013 | Foundation Medicine filed plans this week to raise $86.25 million in an IPO, and the Boston Globe posits it could be aiming too low. Another recent Third Rock Ventures biotech raised more than 20% more than it expected last week and Foundation Medicine's technology is strong. For background see Laying the Foundation for Next-Gen Cancer Diagnostics and Foundation Medicine Partners with Memorial Sloan-Kettering. Boston Globe
View Next Related Story
Click here to login and leave a comment.  


Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact Angela Parsons, 781.972.5467.